Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes?

San Donato Group (GSD)

Status: Completed

Conditions: Prostate Cancer

Treatments: Diagnostic Test: Diagnostic accuracy

Study type: Observational

Funder types: Other

Identifiers

NCT06170164

Colina-HTT-LN

Details and patient eligibility

About

The role of PET/CT with Choline in the restaging of prostatic disease is now universally recognized, and its use has become routine in numerous centers in Italy and abroad. The indication for the test is provided exclusively by an increase in PSA. It was interesting to understand whether these prognostic factors have an influence on the probability of detecting disease by PET with Choline to identify patients who have a greater probability of benefiting from the use of this method with the possibility of identifying the disease in earlier stages.

Enrollment: 68 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients operated with radical prostatectomy
• patients that present biochemical recurrence of the disease;

Exclusion criteria

• patients <18 years